Cilostazol controlled release (Genovate Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCilostazol controlled release (Genovate Biotechnology)
Drug Alias NamePMRCilostazol controlled release
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsIntermittent Claudication
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenovate Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenovate Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsIntermittent Claudication
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A